We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$906M
AUM Growth
+$185M
Cap. Flow
+$148M
Cap. Flow %
16.31%
Top 10 Hldgs %
24.88%
Holding
586
New
69
Increased
148
Reduced
238
Closed
71

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$23.7M
2
DB icon
Deutsche Bank
DB
+$15.9M
3
UNH icon
UnitedHealth
UNH
+$14.4M
4
COR icon
Cencora
COR
+$13.9M
5
OCR
OMNICARE INC
OCR
+$13.7M

Sector Composition

Rank Sector Weight
1 Industrials 17.33%
2 Consumer Discretionary 11.57%
3 Healthcare 7.92%
4 Utilities 7.88%
5 Materials 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLT icon
301
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
$59.7K 0.01%
457
-299
-40% -$39K
IJH icon
302
iShares Core S&P Mid-Cap ETF
IJH
$121B
$59.4K 0.01%
+1,955
New +$57.8K
CP icon
303
Canadian Pacific Kansas City
CP
$81B
$58.9K 0.01%
1,630
-4,000
-71% -$148K
DO
304
DELISTED
Diamond Offshore Drilling
DO
$58.8K 0.01%
2,194
+83
+4% +$2.59K
NOV icon
305
NOV
NOV
$6.84B
$58.7K 0.01%
1,175
+24
+2% +$1.3K
FXA icon
306
Invesco CurrencyShares Australian Dollar Trust
FXA
$96.4M
$58.1K 0.01%
+762
New +$59.9K
ESV
307
DELISTED
Ensco Rowan plc
ESV
$56.8K 0.01%
675
+109
+19% +$11.5K
EWU icon
308
iShares MSCI United Kingdom ETF
EWU
$4.1B
$52.2K 0.01%
1,450
DDD icon
309
3D Systems Corp
DDD
$405M
$52.2K 0.01%
1,902
-882
-32% -$26K
EA icon
310
Electronic Arts
EA
$52.7B
$52.1K 0.01%
886
-1,766
-67% -$95.2K
REGN icon
311
Regeneron Pharmaceuticals
REGN
$72.9B
$51.9K 0.01%
115
+3
+3% +$1.27K
EOG icon
312
EOG Resources
EOG
$77.7B
$51.7K 0.01%
564
-298
-35% -$26.9K
IMO icon
313
Imperial Oil
IMO
$62.3B
$51.3K 0.01%
1,287
-846
-40% -$33K
BHI
314
DELISTED
Baker Hughes
BHI
$50.5K 0.01%
795
+606
+321% +$36.6K
VOD icon
315
PUT
Vodafone
VOD
$37.1B
$50.2K 0.01%
50
AMBA icon
316
Ambarella
AMBA
$3.04B
$50.1K 0.01%
+662
New +$40.2K
BRK.B icon
317
Berkshire Hathaway Class B
BRK.B
$1.1T
$49.4K 0.01%
342
+33
+11% +$4.86K
GGAL icon
318
Galicia Financial Group
GGAL
$7.89B
$47.9K 0.01%
2,067
-26,394
-93% -$521K
CRC
319
DELISTED
California Resources Corporation
CRC
$44.9K 0.01%
590
FLS icon
320
Flowserve
FLS
$8.94B
$44K ﹤0.01%
779
-1,889
-71% -$110K
LII icon
321
Lennox International
LII
$15B
$43.9K ﹤0.01%
393
-13
-3% -$1.34K
FTR
322
DELISTED
Frontier Communications Corp.
FTR
$43.8K ﹤0.01%
+414
New +$45.8K
TRP icon
323
TC Energy
TRP
$70.1B
$43.6K ﹤0.01%
1,018
-2,300
-69% -$103K
TCOM icon
324
Trip.com Group
TCOM
$29B
$43.4K ﹤0.01%
+1,480
New +$35.7K
COR icon
325
Cencora
COR
$62B
$42.7K ﹤0.01%
376
-137,984
-100% -$13.9M

Similar funds

Exane Derivatives's Q1 2015 Portfolio in Review

As of Q1 2015, Exane Derivatives held 586 positions worth $906M, up 26% from $721M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Exane Derivatives deployed $148M of net new capital in Q1 2015, opening 69 new positions and adding to 148 existing holdings. Its largest new stake was WEC Energy: 438,756 shares worth $21.7M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 6.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $23.7M trimmed.

  • Exane Derivatives's largest Q1 2015 buy was WEC Energy: 438,756 shares worth $21.7M.
  • Exane Derivatives added most to Delta Air Lines in Q1 2015, an estimated $23.1M increase.
  • Exane Derivatives's biggest Q1 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $23.7M.
  • Exane Derivatives fully exited O'Reilly Automotive in Q1 2015, selling an estimated $13.3M.
  • Exane Derivatives's ten largest holdings make up 25% of its $906M portfolio in Q1 2015.
  • Exane Derivatives opened 69 new positions and closed 71 in Q1 2015.
  • Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $906M.

Based on Exane Derivatives's 13F filing for Q1 2015, filed 15 May 2015.